Post
Mucocort canker sore patch trial approved in native Sweden
Swedish startup Mucocort has received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to commence …
OCT Europe: AI and RWD can avoid data replication in trials
AI and real-world data (RWD) can save investigators hours and avoid the need for data replication in clinical trials. Mats Sugden, …
Insmed’s brensocatib: A candidate for bronchiectasis treatment, closer to approval
Insmed has been in the spotlight over the past few years for its pipeline agent, brensocatib, which has previously shown …
Study identifies racial disparities in avoidable hospitalisations in nursing homes
An expanding body of research has shed light on racial disparities in the health outcomes of patients with neurodegenerative diseases. …
AngioDynamics touts positive data from AlphaVac trial
US-based device company AngioDynamics has announced new data that finds its AlphaVac F1885 System safe in patients with acute intermediate-risk …
Researchers hit ‘milestone’ in light therapy for spinal cord injury study
Scientists at the University of Birmingham, UK, have developed a method to repair nerve connections for patients with spinal cord …
VYNE Therapeutics receives FDA approval for trial of VYN202
US-based biopharmaceutical company VYNE Therapeutics has received US Food and Drug Administration clearance for its investigational new drug (IND) application …
Adcentrx receives NMPA approval for solid tumour therapy trial
China’s National Medical Products Administration (NMPA) has approved an investigational new drug (IND) application from Adcentrx Therapeutics to begin a …
GlycoMimetics reports data from Phase III AML treatment trial
US-based biotechnology company GlycoMimetics has released topline results from its Phase III clinical trial of uproleselan, an E-selectin antagonist designed …
Edgewise Therapeutics doses first subject in HCM drug trial
US-based biopharmaceutical company Edgewise Therapeutics has dosed the first subject in the Phase II CIRRUS-HCM clinical trial of EDG-7500, a …
HanAll Biopharma initiates Phase III DED treatment trial
HanAll Biopharma has commenced the Phase III VELOS-4 trial for tanfanercept, a new topical anti-inflammatory treatment for moderate to severe …
Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
Novo Nordisk has dosed the first subject in a Phase I clinical trial of the oral NLRP3 inhibitor NNC6022-0001 (formerly …
Boehringer reports positive findings from diabetic macular ischemia trial
Boehringer Ingelheim has reported positive data from the HORNBILL Phase I/IIa clinical trial of the humanised monoclonal anti-Sema3A antibody, BI …
Johnson & Johnson reports data from Phase II prostate cancer trial
Johnson & Johnson has released results from a Phase II clinical trial evaluating ERLEADA (apalutamide) as an adjuvant therapy with …
MMI pioneers Symani Surgical System in first US cases
Medical Microinstruments (MMI) has announced the completion of its first two clinical cases in the US using the FDA-approved Symani …